Early-Stage Lung Cancer Treatment Disparities by Race Among Medicare Beneficiaries
This study suggests that racial disparities in the receipt of curative treatment for early-stage NSCLC among Medicare beneficiaries have persisted since the 1990s, with the most marked differences in the receipt of surgical treatment and significant racial differences in the receipt of SBRT as the therapy emerged. Further work must explore factors that can address and mitigate these disparities.
Authors
- Jeph Herrin (ORCID: https://orcid.org/0000-0002-3671-3622)
- Cary P. Gross (ORCID: https://orcid.org/0000-0002-4974-935X)
- Olivia F. Lynch
- Victor Lee (ORCID: https://orcid.org/0000-0002-6283-978X)
- Pamela R. Soulos
- James B. Yu
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- Yale Cancer Center (US)
- Yale University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.59845
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00